• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


BioBAT Brings Bioscience Research To Brooklyn, New York

Brooklyn, New York will soon be home to a massive new bio-research and manufacturing facility. BioBAT, a 486,000-square-foot center for commercial bioscience will create more than 1,000 permanent jobs at the Brooklyn Army Terminal. The project, a partnership between New York City and SUNY Downstate Medical Center, will complete its first phase of construction by 2011.

"With the development of BioBAT, together with the East River Science Park set to open this fall, we are building 10 times the amount of commercial lab space that's currently available," said New York City Mayor Michael R. Bloomberg.

The City invested $12 million in the project, and the state offered $48 million of funding. Some organizations, such as the International AIDS Vaccine Initiative, are already located there, and will be joined by several others.

"BioBAT's laboratory, office, and manufacturing space on the Brooklyn waterfront is designed for larger companies and offers affordable rents, convenient transportation, and access to all the leading academic research centers in the city," said SUNY Downstate President John C. LaRosa.

The Brooklyn Army Terminal is a 97-acre facility owned by the city and managed by the New York City Economic Development Corporation. BioBAT is a nonprofit corporation that was created to encourage the development of commercial bioscience research, development, and manufacturing in Brooklyn. The architecture firm HOK will design the facility.

Exclusive Research